Aspirin intolerance and the need for dual antiplatelet therapy after stent implantation: A proposed alternative regimen
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference25 articles.
1. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (FANTASTIC) study;Bertrand;Circulation,1998
2. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance;Colombo;Circulation,1995
3. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators;Leon;N Engl J Med,1998
4. Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment;Airoldi;Circulation,2007
5. Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation;Rossini;Am J Cardiol,2008
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The safety and efficacy of indobufen or aspirin combined with clopidogrel in patients with acute myocardial infarction after percutaneous coronary intervention;Platelets;2024-06-19
2. Drug-Delivery Silver Nanoparticles: A New Perspective for Phenindione as an Anticoagulant;Biomedicines;2023-08-04
3. Indobufen versus aspirin in patients with acute ischaemic stroke in China (INSURE): a randomised, double-blind, double-dummy, active control, non-inferiority trial;The Lancet Neurology;2023-06
4. Indobufen or Aspirin on Top of Clopidogrel After Coronary Drug-Eluting Stent Implantation (OPTION): A Randomized, Open-Label, End Point–Blinded, Noninferiority Trial;Circulation;2023-01-17
5. Shexiang Baoxin Pill (MUSKARDIA) reduces major adverse cardiovascular events in women with stable coronary artery disease: A subgroup analysis of a phase IV randomized clinical trial;Frontiers in Cardiovascular Medicine;2022-10-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3